313 related articles for article (PubMed ID: 28786523)
21. Farnesoid X Receptor (FXR) Interacts with Camp Response Element Binding Protein (CREB) to Modulate Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Secretion by Intestinal L Cell.
Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
Cell Physiol Biochem; 2018; 47(4):1442-1452. PubMed ID: 29940597
[TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.
Rehfeld JF; Knop FK; Asmar A; Madsbad S; Holst JJ; Asmar M
Scand J Gastroenterol; 2018 Dec; 53(12):1429-1432. PubMed ID: 30449207
[TBL] [Abstract][Full Text] [Related]
23. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers.
Adrian TE; Gariballa S; Parekh KA; Thomas SA; Saadi H; Al Kaabi J; Nagelkerke N; Gedulin B; Young AA
Diabetologia; 2012 Sep; 55(9):2343-7. PubMed ID: 22696033
[TBL] [Abstract][Full Text] [Related]
24. Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?
Asmar M; Bache M; Knop FK; Madsbad S; Holst JJ
J Clin Endocrinol Metab; 2010 May; 95(5):2367-75. PubMed ID: 20194711
[TBL] [Abstract][Full Text] [Related]
25. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T
Diabetes Obes Metab; 2010 Apr; 12(4):323-33. PubMed ID: 20380653
[TBL] [Abstract][Full Text] [Related]
26. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes.
Calderon G; McRae A; Rievaj J; Davis J; Zandvakili I; Linker-Nord S; Burton D; Roberts G; Reimann F; Gedulin B; Vella A; LaRusso NF; Camilleri M; Gribble FM; Acosta A
EBioMedicine; 2020 May; 55():102759. PubMed ID: 32344198
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.
Yusta B; Matthews D; Flock GB; Ussher JR; Lavoie B; Mawe GM; Drucker DJ
Mol Metab; 2017 Jun; 6(6):503-511. PubMed ID: 28580281
[TBL] [Abstract][Full Text] [Related]
28. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance.
Yan X; Li P; Tang Z; Feng B
BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907
[TBL] [Abstract][Full Text] [Related]
29. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
30. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes.
Borg MJ; Bound M; Grivell J; Sun Z; Jones KL; Horowitz M; Rayner CK; Wu T
Diabetes Obes Metab; 2019 Mar; 21(3):640-647. PubMed ID: 30370686
[TBL] [Abstract][Full Text] [Related]
32. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
[TBL] [Abstract][Full Text] [Related]
33. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A
Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290
[TBL] [Abstract][Full Text] [Related]
34. Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects.
Keller J; Trautmann ME; Haber H; Tham LS; Hunt T; Mace K; Linnebjerg H
Regul Pept; 2012 Nov; 179(1-3):77-83. PubMed ID: 22960288
[TBL] [Abstract][Full Text] [Related]
35. Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell.
Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
J Cell Physiol; 2019 Aug; 234(8):12839-12846. PubMed ID: 30536761
[TBL] [Abstract][Full Text] [Related]
36. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
Katsuma S; Hirasawa A; Tsujimoto G
Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.
Chen L; Yao X; Young A; McNulty J; Anderson D; Liu Y; Nystrom C; Croom D; Ross S; Collins J; Rajpal D; Hamlet K; Smith C; Gedulin B
Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E68-76. PubMed ID: 21934041
[TBL] [Abstract][Full Text] [Related]
38. Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors.
Brighton CA; Rievaj J; Kuhre RE; Glass LL; Schoonjans K; Holst JJ; Gribble FM; Reimann F
Endocrinology; 2015 Nov; 156(11):3961-70. PubMed ID: 26280129
[TBL] [Abstract][Full Text] [Related]
39. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA
J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773
[TBL] [Abstract][Full Text] [Related]
40. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
